WHO. Investment case for eliminating mother-to-child transmission of syphilis, pp. 1–40. WHO, 2012.
WHO. Prevalence and incidence of selected sexually transmitted infections, pp. 1–38. WHO, 2011.
Newman, L, et al.
Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Medicine
2013; 10: e1001396.
Fenton, KA, et al.
Infectious syphilis in high-income settings in the 21st century. Lancet Infectious Diseases
2008; 8: 245–253.
LaFond, RE, Lukehart, SA. Biological basis for syphilis. Clinical Microbiology Reviews
2006; 19: 29–49.
Kalichman, SC, Pellowski, J, Turner, C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sexually Transmitted Infections
2011; 87: 183–190.
Johnson, LF, Lewis, DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sexually Transmitted Diseases
2008; 35: 946–959.
Røttingen, J-A, Cameron, DW, Garnett, GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?
Sexually Transmitted Diseases
2001; 28: 579–597.
Boily, M-C, et al.
Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infectious Diseases
2009; 9: 118–129.
Rotchford, K, Strum, WA, Wilkinson, D. Effect of coinfection with STDs and of STD treatment on HIV Shedding in genital-tract secretions: systematic review and data synthesis. Sexually Transmitted Diseases
2000; 27: 243–248.
Champredon, D, et al.
The effect of sexually transmitted co-infections on HIV viral load amongst individuals on antiretroviral therapy: a systematic review and meta-analysis. BMC Infectious Diseases
2015; 15: 1–11.
Reynolds, SJ, et al.
High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India. Sexually Transmitted Infections
2006; 82: 121–126.
Fleming, DT, Wasserheit, JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections
1999; 75: 3–17.
Baggaley, RF, Hollingsworth, TD. Brief report: HIV-1 transmissions during asymptomatic infection: exploring the impact of changes in HIV-1 viral load due to coinfections. Journal of AIDS
2015; 68: 594–598.
Cameron, CE, Lukehart, SA. Current status of syphilis vaccine development: need, challenges, prospects. Vaccine
2014; 32: 1602–1609.
Miller, JN. Immunity in experimental syphilis VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by γ-irradiation. Journal of Immunology
1973; 110: 1206–1215.
CDC. Syphilis elimination communication plan, pp. 1–23, 2001.
CDC. The national plan to eliminate syphilis from the United States, pp. 1–66, 2006.
WHO. The global elimination of congenital syphilis: rationale and strategy for action, pp. 1–46. WHO, 2007.
Broutet, N, et al.
Vaccines against sexually transmitted infections: the way forward. Vaccine
2014; 32: 1630–1637.
Sexton, J, Garnett, G, Røttingen, J-A. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sexually Transmitted Diseases
2005; 32: 351–357.
Buchacz, K, et al.
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS
2004; 18: 2075–2079.
Vidor, E. Evaluation of the persistence of vaccine-induced protection with human vaccines. Journal of Comparative Pathology
2010; 142: S96–S101.
CDC. Sexually transmitted disease surveillance 2014, pp. 1–177, 2015.
Grosskurth, H, et al.
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet
1995; 346: 530–536.
Wawer, MJ, et al.
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet
1999; 353: 525–535.
Kamali, A, et al.
Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Genitourinary Medicine
1999; 75: 98–102.
Gregson, S, et al.
Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in Eastern Zimbabwe. PLoS Medicine
2007; 4: e102.
Watson-Jones, D, et al.
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. New England Journal of Medicine
2008; 358: 1560–1571.
Celum, C, et al.
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet
2008; 371: 2109–2119.
Ghys, PD, et al.
Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers. AIDS
2001; 15: 1421–1431.
Kaul, R, et al.
Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers. Journal of the American Medical Association
2004; 291: 2555–2562.
Hayes, RJ, et al.
Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?
2010; 24: S15–S26.